Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.

Please provide your email address to receive an email when new articles are posted on . A variety of options/tools are needed when treating patients with severe emphysema and breathlessness. A phase 3 ...

Dec. 10—(StatePoint) More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD.

Severe emphysema is common, is associated with severe symptoms and disability, entails much utilization of healthcare, and lacks disease-modifying treatments. Since the 1960s, various palliative ...

One patient could only walk 15 to 20 steps before needing to get back on her oxygen, making it difficult to find motivation to engage in daily activities. Another patient struggled with severe ...

Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...

NEW YORK (Reuters Health) - Treatment with a stent coated with the drug paclitaxel to reduce hyperinflation of the lungs appears to be a feasible treatment for patients with severe emphysema, ...

Outcomes after bronchoscopic lung volume reduction (BLVR) for patients with advanced emphysema were not significantly affected by the level of heterogeneity before the procedure, based on data from ...

Apreo Health Closes $130 Million Series B Financing to Advance Pivotal Trial and Early Commercialization of Breakthrough Airway Scaffold for Severe Emphysema Apreo Health, a clinical-stage medical ...